Real-time quantitative PCR for human herpesvirus 6 DNA

Area of Science:

• Virology
• Molecular Diagnostics
• Infectious Diseases

Background:

• Diagnosing human herpesvirus 6 (HHV-6) infection is challenging due to limitations in current methods.
• Existing tools like antibody titers and qualitative PCR cannot differentiate latent from active HHV-6 infections.

Purpose of the Study:

• To develop a highly sensitive and accurate quantitative PCR assay for measuring HHV-6 DNA.
• To enable differentiation between latent and active HHV-6 infections.

Main Methods:

• A novel 5' nuclease, fluorogenic real-time PCR assay was developed using the ABI PRISM 7700 system.
• The assay quantifies HHV-6 DNA in tissue-derived cell suspensions and body fluids.
• Sensitivity was compared to nested PCR, and accuracy/reproducibility to quantitative-competitive PCR.

Main Results:

• The new assay demonstrated high sensitivity (1 viral genome equivalent/test) for both HHV-6 subgroups A and B.
• It exhibited a broad dynamic detection range (1-10^6 viral genome equivalents/test).
• The method showed superior accuracy, repeatability, and reproducibility compared to standard quantitative-competitive PCR.

Conclusions:

• This quantitative PCR assay provides accurate measurement of HHV-6 DNA in diverse biological samples.
• Its high sensitivity, dynamic range, and reproducibility make it suitable for clinical diagnostics and large-scale epidemiological studies.
• The assay effectively distinguishes active from latent HHV-6 infections, addressing a critical diagnostic gap.